Thank you for getting in touch. Please note this is an automated email.
Your receipt of this means that we have safely received your email.

We are currently receiving a high volume of requests and there will be a
delay in getting back to you with a further acknowledgement. We will do so
as soon as we can.

Since 6 December 2023, the GMC has been subject to the Welsh Language
Standards. You are welcome to contact us in Welsh and we will respond in
Welsh, without this causing additional delay.

In the meantime, if you want any further information about the GMC, please
visit our website: [1]Home - GMC (gmc-uk.org)

General Medical Council

We work with doctors, patients, and other stakeholders to support good,
safe patient care across the UK. We set the standards doctors and those
who train them need to meet, and help them achieve them. If there are
concerns these standards may not be met or that public confidence in
doctors may be at risk, we can investigate, and take action if needed.

This email may contain privileged or confidential information which should
only be used for the purpose for which it has been sent.

If you are not the addressee or have received this email in error, please
do not read, print, re-transmit, store or act in reliance on it or any
attachments. Please email the sender and then immediately delete it.

The General Medical Council is a charity registered in England and Wales
(1089278) and in Scotland (SC037750)

You are welcome to contact us in Welsh. We will respond in Welsh, without
this causing additional delay.

_________________________________________________________________

Cyngor Meddygol Cyffredinol

Rydym yn gweithio gyda meddygon, cleifion a rhanddeiliaid eraill i
gynorthwyo gofal da a diogel i gleifion ar draws y DU. Rydym yn gosod y
safonau y bydd angen i feddygon a’r rhai sy’n eu hyfforddi eu bodloni, ac
yn eu helpu i’w cyflawni. Os bydd pryderon efallai na fydd y safonau hyn
yn cael eu cyflawni neu y gallai hyder y cyhoedd mewn meddygon fod mewn
perygl, gallwn ymchwilio, a gweithredu os oes angen.

Efallai bod y neges e-bost hon yn cynnwys gwybodaeth freiniol neu
gyfrinachol, y dylid ei defnyddio at y diben y’i hanfonwyd yn unig.

Os nad chi yw’r derbynnydd neu os ydych chi wedi cael yr e-bost hwn mewn
camgymeriad, peidiwch â’i ddarllen, argraffu, ail-anfon, storio na
gweithredu mewn ffordd sy’n dibynnu arni neu unrhyw atodiadau os gwelwch
yn dda. Dylech anfon e-bost at yr anfonwr ac yna, ei ddileu ar unwaith.

Mae’r Cyngor Meddygol Cyffredinol yn elusen gofrestredig yng Nghymru a
Lloegr (1089278) ac yn Yr Alban (SC037750)

Mae croeso i chi gysylltu â ni yn Gymraeg. Byddwn yn ymateb yn Gymraeg,
heb i hyn achosi oedi ychwanegol.

References

Visible links
1. https://www.gmc-uk.org/

Dear Mr Clayton,

Your information request - IR1-4631177748

Thank you for your email dated 11 October.

How we will consider your request

We’re going to consider your request under the Freedom of Information Act
2000 (FOIA). The FOIA gives us 20 working days to respond, but we’ll come
back to you as soon as we can.

Yours sincerely

Information Access Team

General Medical Council

3 Hardman Street

Manchester

M3 3AW

From: Ian Clayton <[FOI #1185973 email]>
Sent: Friday, October 11, 2024 12:32 PM
To: FOI <[email address]>
Subject: Freedom of Information request - Investments held by the GMC

Dear General Medical Council, It is well established within the public
domain that the General Medical Council have held and perhaps still hold
incestments in (a) AstraZeneca and (b) Merck, as well as other
pharmaceutical organisationns, as

Dear General Medical Council,

It is well established within the public domain that the General Medical Council have held and perhaps still hold incestments in (a) AstraZeneca and (b) Merck, as well as other pharmaceutical organisationns, as was revealed in the response a 2023 FOIA request raised by the British Medical Journal.

I would now please,  like to request the following:

(1) Full details of the amount of the financial investments made in each respective organisation referred to above.

(2) Fill details of when the investments were made in the said organisations referred to bybthe GMC.

(3) Confirmation that investments are still held in such organisations referred to by the GMC, or, if not, then the date(s) upon which the GMC withdrew from the holding of such investment(s).

Yours faithfully,

Ian Clayton

-------------------------------------------------------------------

Please use this email address for all replies to this request:

[1][FOI #1185973 email]

Is [2][GMC request email] the wrong address for Freedom of Information requests to General Medical Council? If so, please contact us using this form:

[3]https://urldefense.com/v3/__https://www....

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:

[4]https://urldefense.com/v3/__https://www....

For more detailed guidance on safely disclosing information, read the latest advice from the ICO:

[5]https://urldefense.com/v3/__https://www....

[6]https://urldefense.com/v3/__https://www....

Please note that in some cases publication of requests and responses will be delayed.

If you find this service useful as an FOI officer, please ask your web manager to link to us from your organisation's FOI page.

show quoted sections

Dear Ian Clayton

Your information access request IR1-4631177748

Thank you for your email of 11 October asking for information regarding
the GMC’s investments in AstraZeneca, Merck, and other pharmaceutical
organisations. I’ve considered your request under the Freedom of
Information Act 2000 (FOIA).

For the purposes of the response, we have defined pharmaceutical companies
in accordance with the Global Industry Classification Standard (GICS)
sub-industries classification for pharmaceutical stocks.

(1) Full details of the amount of the financial investments made in each respective organisation referred to above.

We currently hold shares in the following pharmaceutical companies:

AstraZeneca: 864 shares with a net market value of £100,880 (amounting to 0.16% of our investment portfolio) as of 29 October 2024.

Novo Nordisk: 885 shares with a net market value of £75,202 (amounting to 0.12% of our investment portfolio) as of 29 October 2024.

(2) Full details of when the investments were made in the said organisations referred to by the GMC.

(3) Confirmation that investments are still held in such organisations referred to by the GMC, or, if not, then the date(s) upon which the GMC withdrew from the holding of such investment(s).

Regarding points (2) and (3) of your request, the table below sets out the
first and last trade date of each holding in pharmaceutical
companies. Where a date of sale is given, the stocks are no longer held.
The grey rows denote stocks that are still held, therefore there is no
date of sale.

Fund Name Trade Date Transaction Type Security Description
General Medical
Council 17/06/2022 First Purchased AstraZeneca
General Medical
Council 03/04/2019 First Purchased Elanco Animal Health
General Medical Sale (stock no longer
Council 26/05/2020 held) Elanco Animal Health
General Medical
Council 23/07/2019 First Purchased Merck & Co Com
General Medical Sale (stock no longer
Council 23/08/2023 held) Merck & Co Com
General Medical
Council 11/12/2018 First Purchased Novartis
General Medical Sale (stock no longer
Council 14/09/2020 held) Novartis
General Medical
Council 14/09/2020 First Purchased Novo Nordisk
General Medical
Council 11/12/2018 First Purchased Roche Holding
General Medical Sale (stock no longer
Council 17/02/2023 held) Roche Holding
General Medical
Council 10/12/2018 First Purchased Zoetis Inc Com
General Medical Sale (stock no longer
Council 25/06/2024 held) Zoetis Inc Com

Who to contact

I hope you find this information useful. If you have any queries about
this, or need anything further, please contact me on the details below.

Yours sincerely

Edd Mustill

Information Access Officer

Information Access Team

General Medical Council

[1]www.gmc-uk.org

E: [2][email address]

T: 0161 250 6949

From: FOI
Sent: Tuesday, October 15, 2024 2:45 PM
To: Ian Clayton <[FOI #1185973 email]>
Subject: RE: Freedom of Information request - Investments held by the GMC

Dear Mr Clayton,

Your information request - IR1-4631177748

Thank you for your email dated 11 October.

How we will consider your request

We’re going to consider your request under the Freedom of Information Act
2000 (FOIA). The FOIA gives us 20 working days to respond, but we’ll come
back to you as soon as we can.

Yours sincerely

Information Access Team

General Medical Council

3 Hardman Street

Manchester

M3 3AW

From: Ian Clayton <[3][FOI #1185973 email]>
Sent: Friday, October 11, 2024 12:32 PM
To: FOI <[4][email address]>
Subject: Freedom of Information request - Investments held by the GMC

Dear General Medical Council, It is well established within the public
domain that the General Medical Council have held and perhaps still hold
incestments in (a) AstraZeneca and (b) Merck, as well as other
pharmaceutical organisationns, as

Dear General Medical Council,

It is well established within the public domain that the General Medical Council have held and perhaps still hold incestments in (a) AstraZeneca and (b) Merck, as well as other pharmaceutical organisationns, as was revealed in the response a 2023 FOIA request raised by the British Medical Journal.

I would now please,  like to request the following:

(1) Full details of the amount of the financial investments made in each respective organisation referred to above.

(2) Fill details of when the investments were made in the said organisations referred to bybthe GMC.

(3) Confirmation that investments are still held in such organisations referred to by the GMC, or, if not, then the date(s) upon which the GMC withdrew from the holding of such investment(s).

Yours faithfully,

Ian Clayton

-------------------------------------------------------------------

Please use this email address for all replies to this request:

[5][FOI #1185973 email]

Is [6][GMC request email] the wrong address for Freedom of Information requests to General Medical Council? If so, please contact us using this form:

[7]https://urldefense.com/v3/__https://www....

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:

[8]https://urldefense.com/v3/__https://www....

For more detailed guidance on safely disclosing information, read the latest advice from the ICO:

[9]https://urldefense.com/v3/__https://www....

[10]https://urldefense.com/v3/__https://www....

Please note that in some cases publication of requests and responses will be delayed.

If you find this service useful as an FOI officer, please ask your web manager to link to us from your organisation's FOI page.

show quoted sections